





































Complexity of the mechanisms which reduce 
regenerative capacity of the liver 
 
Age-associate inhibition of liver proliferation has been 
described over 50 years ago [2] and has been the subject 
of intensive investigations especially during last 6 years.  
The initial studies have been focused on the 
investigations of the role of individual genes in the 
inhibition of liver proliferation [3, 4, 5].   However, 
several recent papers have found that the inhibition of 
liver proliferation in old mice is associated with 
formation of multi-protein C/EBPα-Brm complexes in 
nucleus [6, 7] and multi-protein complexes of RNA 
binding protein CUGBP1 with translation initiation 
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showed that these complexes alter transcription and 
translation in livers of old mice [10-13].   It has been 
later shown that the activation of CUGBP1 in livers of 
old mice leads to the translational elevation of a 
chromatin remodeling protein histone deacetylase 1, 
HDAC1, which joins the C/EBPα-Brm complex and 
silences promoters of the cell cycle genes [10].  In 
addition to the intracellular alterations, Rando’s group 
has found that systemic environment of young animals 
reduces C/EBPα-Brm complex and corrects liver 
proliferation [7].  We have recently found that glycogen 
synthase 3β, GSK3β, is a key enzyme which regulates 
these pathways in the liver and that the decline of 
GSK3β with age causes inhibition of liver proliferation 
via stabilization of cyclin D3 and following changes in 
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age-associated mechanisms of inhibition of liver 
proliferation in the light of this recent finding. 
 
GSK3β regulates transcription and translation in the 
liver via control of cyclin D3 
 
GSK3β is a ubiquitously expressed multifunctional 
serine/threonine protein kinase originally identified as a 
key regulator of insulin-dependent glycogen synthesis 
[14, 15].  GSK3β phosphorylates a number of substrates 
which are involved in embryonic development, protein 
synthesis, mitosis, and survival [16-19]).  In addition to 
these activities, GSK3β has been shown to support cell 
proliferation and liver regeneration [20, 21].  Little is 
known about the mechanisms by which GSK3β 
regulates cell proliferation. It has been shown that 
GSK3β inhibits Wnt signaling through stabilization of 
β-catenin and that this pathway is involved in 
development of cancer [22, 23]. The essential role of 
active GSK3β in cell survival has been shown in the 
studies of GSK3β-null mice which die during 
embryogenesis due to liver degeneration caused by 
widespread hepatocyte apoptosis [24].  Several papers 
showed that inappropriate modulation of GSK3β 
activity plays critical role in the age-related pathologies 
such as Alzheimer's disease, noninsulin-dependent 
diabetes mellitus, inflammation, and cancer [21, 25, 26, 
27, 28].  We have recently identified mechanisms by 
which GSK3β regulates biological functions of the liver 
and mechanisms by which aging reduces GSK3β in the 
liver and alters two levels of regulation of gene 
expression: transcription and translation through the 
reduction of GSK3β [1].  In livers of young mice, 
GSK3β phosphorylates cyclin D3 and controls cyclin 
D3-cdk4 on relatively low levels. Our data show that 
GSK3β is reduced with age and that the age-associated 
decline of GSK3β leads to stabilization of cyclin D3 
and following accumulation of transcriptional C/EBPα-
Brm and translational CUGBP1-eIF2 complexes 
(Figure 1). We suggest that the alterations in epigenetic 
repression of genes and alterations in translation of 
certain proteins result in development of aging 
phenotype in the liver.  What target genes might be 
affected by these two multi-protein complexes?  The 
C/EBPα-Brm complex binds to and represses the 
promoters of S-phase specific genes [29].  We have 
shown that the CUGBP1-eIF2 complex increases 
translation of two proteins, C/EBPβ and HDAC1, in 
livers of old mice. The biological consequences of the 
elevation of C/EBPβ and HDAC1 are discussed in our 
recent review [30].  In summary, our findings placed 
GSK3β in the network which regulates transcription and 
translation in the liver and emphasized the role of 
decline of GSK3β in development of aging phenotype 
in the liver.  In agreement with our findings, Seo et al 
have recently found that the inactivation of GSK3β by 
specific inhibitors, by dominant negative mutant 
GSK3β-K85A or by siRNA effectively induces 
senescence phenotype in human liver-derived Chang 
cells [31]. Taken together our results and these data, we 
suggest that the decline or inactivation of GSK3β play a 
critical role in the development of senescence 
phenotype in the liver.  







































GSK3β-cyclin D3 pathway is altered in brain, lung 
and adipose tissues of old mice  
 
Systemic environment of young mice corrects 
proliferation of the liver and regeneration of skeletal 
muscle in old mice [7]. Because growth hormone (GH) 
Figure 1. A hypothesis for the role of reduction of GSK3β in
development of aging phenotype in the liver. GSK3β triggers
degradation  of  cyclin  D3  in  livers  of  young  mice.  The  age‐
associated  decline  of  growth  hormone  and  GSK3β  leads  to  the
stabilization  of  cyclin  D3  and  to  formation  of  transcriptional
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because it is one of the components of the systemic 
environment which is reduced with age, we suggested 
that GH might also regulate GSK3β-cyclin D3 pathway 
in other tissues. Given the fact that the target of cyclin 
D3/cdk4, C/EBPα, is expressed at high levels in brain, 
lung and adipose tissue, we have examined the GSK3β-
cyclin D3 pathway in these additional tissues.  Similar 
to alterations in the liver, we found the age-associated 
reduction of GSK3β and elevation of cyclin D3 in all 
tested tissues.  It is interesting that the administration of 
GH restores GSK3β-cyclin D3 pathway in these tissues 
[1]. Although our studies were focused on the liver and 
on two known targets of cyclin D3, C/EBPα and 
CUGBP1, the age-associated alterations of GSK3β and 
cyclin D3-cdk4 presumably affect several other targets 
in different tissues. The future studies are required for 
understanding of all biological consequences of 
alterations in GSK3β-cyclin D3 pathway. It would be 
interesting to examine additional tissue-specific targets 
of both cyclin D3/cdk4 and GSK3β in tissues of old 
mice. In skeletal muscle, cyclin D3-cdk4 interacts with 
MyoD [32] and potentially the age-associated elevation 
of cyclin D3-cdk4 might re-program expression of 
genes in skeletal muscle through MyoD.  It is also 
interesting to determine if the reduction of GSK3β in 
tissues of old mice affects pathways which are 
dependent on GSK3β and independent on cyclin 
D3/cdk4.  Since the cytoplasmic target of cyclin D3-
cdk4, CUGBP1, is expressed in all tissues, it would be 
important to examine the age-associated alterations in 
the translational targets of the CUGBP1-eIF2 complex. 
The significance of this pathway is discussed in our 
recent review [30].   In summary, our new data suggest 
that the age-associated alteration of the GSK3β-cyclin 
D3 pathway is one of the critical events in the 
development of aging phenotype in the liver and 
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